October
28
electroCore, Inc. Submits 510(k) Premarket Notification to FDA Seeking Clearance of Quell® for the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy (CIPN)
Submission backed by clinical data from two clinical studies representing 168 subjects, demonstrating quality...